BCR-ABL fusion protein mutant, encoding gene and expression carrier thereof, and construction method and application of the expression carrier
A fusion protein and expression vector technology, applied in application, gene therapy, genetic engineering, etc., to increase sensitivity, overcome potential complications, and promote apoptosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Embodiment 1 Computer simulation technology to construct mutant structure and analysis of binding ability
[0049] According to the ABL SH3 structure in the protein structure database PDB (ID: 3EG2, chainsA, ABL60-121 positions, 62 amino acids in length), mutate glutamine (Q) at position 114 to asparagine (N) and change it back to Wild-type ABL SH3 structure, mutating threonine at position 79 of the wild-type ABL SH3 structure to tyrosine to obtain mutant M3 (T79Y), whose structure is as follows figure 1 Shown, its amino acid sequence is shown in SEQ ID NO:2.
[0050] The key amino acids in the combination of the proline-rich domain of RIN1 and the ABL SH3 domain were analyzed by PepSite2 software. These key amino acids include: Pro, Asn, Phe, Trp, Tyr, and these amino acids have a common structural feature that contains a benzene ring ( Pro, Phe, Trp, Tyr) or phenyl-like rings (Asn).
[0051] Use PyMOL1.6 and VMD1.8.7 to complete point mutation and image visualizatio...
Embodiment 2
[0052] Embodiment 2 Obtaining of Mutant Gene Fragment
[0053] (1) Primer design and synthesis
[0054] According to the SH3 fragment in the ABL gene sequence (sequence number NC_000009.12) in NCBI GenBank, the PCR primers of M0, M1, M2, M3, and M4 were designed by Primer5.0 software. After Blast comparison, the primers were provided by Shanghai Yingjun (Invitrogen) Ltd Synthetics. Among them, the upstream 5' end of the ABL SH3 wild-type (M0) amplification primer (also the outer primer for overlap extension PCR) contains a Sal Ⅰ restriction site, and the downstream primer contains a Xho Ⅰ restriction site and a stop codon. Boxes are stop codons, bold italics are restriction sites, and lowercase letters are mutation sites. The primer sequences and mutation points are listed in Table 1.
[0055] Table 1 ABL SH3 wild type and mutant PCR amplification primer sequences
[0056]
[0057] (2) ABL SH3 wild type (M0) PCR amplification
[0058] The pMig210 plasmid (including BCR...
Embodiment 3
[0069] Embodiment 3 recombinant adenovirus vector construction
[0070] (1) The target gene is cloned into the shuttle vector
[0071] The overlap-extension PCR purification products of M0, M1, M2, M3, and M4 obtained in Example 2, that is, the full-length ABL SH3 mutants, were respectively cloned into the shuttle vector pAdTrack-CMV vector.
[0072] ① The PCR purified product and pAdTrack-CMV vector in Example 2 were double-digested with endonucleases Sal Ⅰ and Xho Ⅰ, respectively, at 37°C overnight;
[0073] ②Purify and recover the digested products, ligate with T4DNA ligase, and ligate overnight at 16°C;
[0074] ③Determine the concentration of the connection product, take 100ng and convert it to CaCl 2 The competent DH5α prepared by the method was cultured on LB plates containing kanamycin at 37°C for 12h;
[0075] ④ Pick a single clone, extract the plasmid after enrichment, and store the strain at -80°C;
[0076] ⑤Use ABLSH3 wild-type (M0) primers for PCR amplificatio...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com